Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

Bibliographic Details
Main Authors: Sarah Orfanos, Ibrahim El Husseini, Thomas Nahass, Jared Radbel, Sabiha Hussain
Format: Article
Language:English
Published: European Respiratory Society 2020-10-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/6/4/00455-2020.full
id doaj-1767ea0065bc46b7b1b10dd267fb318f
record_format Article
spelling doaj-1767ea0065bc46b7b1b10dd267fb318f2021-01-18T17:10:09ZengEuropean Respiratory SocietyERJ Open Research2312-05412020-10-016410.1183/23120541.00455-202000455-2020Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead spaceSarah Orfanos0Ibrahim El Husseini1Thomas Nahass2Jared Radbel3Sabiha Hussain4 Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA Dept of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA http://openres.ersjournals.com/content/6/4/00455-2020.full
collection DOAJ
language English
format Article
sources DOAJ
author Sarah Orfanos
Ibrahim El Husseini
Thomas Nahass
Jared Radbel
Sabiha Hussain
spellingShingle Sarah Orfanos
Ibrahim El Husseini
Thomas Nahass
Jared Radbel
Sabiha Hussain
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
ERJ Open Research
author_facet Sarah Orfanos
Ibrahim El Husseini
Thomas Nahass
Jared Radbel
Sabiha Hussain
author_sort Sarah Orfanos
title Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_short Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_full Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_fullStr Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_full_unstemmed Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
title_sort observational study of the use of recombinant tissue-type plasminogen activator in covid-19 shows a decrease in physiological dead space
publisher European Respiratory Society
series ERJ Open Research
issn 2312-0541
publishDate 2020-10-01
url http://openres.ersjournals.com/content/6/4/00455-2020.full
work_keys_str_mv AT sarahorfanos observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT ibrahimelhusseini observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT thomasnahass observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT jaredradbel observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
AT sabihahussain observationalstudyoftheuseofrecombinanttissuetypeplasminogenactivatorincovid19showsadecreaseinphysiologicaldeadspace
_version_ 1724333049625182208

Similar Items